Acutely ill children (n = 129) aged 1-6 years receiving antibiotic therapy were randomized to receive a nutritional supplement with (PS) or without (P) synbiotics or a fruit-flavored drink (D) with their medications. Group PS had significantly greater weight gains (versus D) following antibiotic therapy. The percentages of subjects without bacterial illnesses 14 days following antibiotic therapy were as follows: 94.3% (PS), 87.8% (D), and 80.6% (P). PS (vs D) significantly increased fecal Lactobacillus in a subset of subjects. Oral supplements increase energy intake and promote weight gain in acutely ill children receiving antibiotics; synbiotics may confer additional benefits by increasing bifidobacteria levels.
Get full access to this article
View all access options for this article.
References
1.
McCarthy D, Kluger M, Vander A. Suppression of food intake during infection: is interieukin-1 involved? Am J Clin Nutr. 1985;42:1179-1182.
2.
Hoerr R, Young V. Alterations in nutrient intake and utilization caused by-disease. Ann NY Acad Sci. 1987;499:124-131.
3.
Scrimshaw N, SanGiovanni J. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr. 1997;66:464S-477S.
4.
Sakata H, Fujita K, Yoshioka H. The effect of antimicrobial agents on fecal flora of children. Antimicrob Agents Chemother. 1986;29:225-229.
5.
Gooch W, Blair E, Puopolo A. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J. 1996;15:157-164.
6.
Hoberman A, Paradise J, Burch D. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of arnoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16:463-470.
7.
Arvola T, Laiho K, Torkkeli S, et al.Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64.
8.
Bender S, Cook A, Hall J, et al.Malnutrition: role of the TwoCal HN Med Pass program. MEDSURG Nursing. 2000;9:284-295.
9.
Donohue D, Salminen S. Safety of probiotic bacteria. Asia Pacific J Clin Nutr. 1996;5:25-28.
10.
Butel MJ, Waligora-Dupriet AJ, Szylit O. Oligofructose and experimental model of neonatal necrotising enterocolitis. Br J Nutr. 2002;87:S213-S219.
Van Niel C, Feudtner C, Garrison M, Christakis D. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109:678-684.
13.
Bengmark S. Use of pro-, pre-, and synbiotics in the ICU—future options. Nutr Hosp. 2001;16:239-256.
14.
Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systemic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001;33:S17-S25.
15.
Duffy LC. Interactions mediating bacterial translocation in the immature intestine. J Nutr. 2000;130:432S-436S.
16.
Marteau P, Boutron-Ruault MC. Nutritional advantages of probiotics and prebiotics. Br J Nutr. 2002;87:S153-S157.
17.
Kaila M, Isolauri E, Soppi E, et al.Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Vaccine. 1992;13:310-312.
18.
Isolauri E, Joensuu J, Suomalainen H, et al.Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine. 1995;13:310-312.
19.
Campbell J, Bauer L, Fahey G, et al.Selected fructooligosaccharide (1 Kestone, Nystose, and 1 F-beta-fructofu ra nosy[nystose) composition of foods and feeds. J Agric Food Chem. 1997;45:3076-3082.
20.
Spiegel J, Rose R, Karabell P, et al.Safety and benefits of fructooligosaccharides as food ingredients. Food Tech. 1994:85-89.
21.
Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics—approaching a definition. Am J Clin Nutr. 2001;73:361S-364S.
22.
Arihara K, Ohihara S, Mukai T, et al.Salivacin 140, a novel bacteriocin from Lactobacillus salivarius subsp. salicinius T140 active against pathogenic bacteria. Lett Appl Microbiol. 1996;22:420-424.
23.
Fuller R. Probiotics in human medicine. Gut. 1991;32:439-442.
24.
Elmer G, Surawicz C, McFarland L. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996;275:870-876.
25.
Astradsson E, Granath L, Heedman PA, Starkhammar H. Cancer patients hospitalised for palliative reasons. Symptoms and needs presented at a university hospital. Support Care Cancer. 2001;9:97-102.
26.
Saarela M, Lahteenmaki L, Crittenden R, et al.Gut bacteria and health foods—the European perspective. Int J Food Micro. 2002;78:99-117.
27.
Chandra RK. Interactions of nutrition, infection and immune response. Immunocompetence in nutritional deficiency, methodological considerations and interventions strategies. Acta Paediatr Scand. 1979;68:137-144.
28.
Scrimshaw N, SanGiovanni J. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr. 1997;66:464S-477S.
29.
Fisberg M, Maulen I, Vasquez E, et al.Effect of oral supplementation with and without synbiotics on catch-up growth in preschool children. J Pediatr Gastroenterol Nutr. 2000;31:S252 (abstract).
30.
Mertsola J, Ziegler T, Ruuskanen O, et al.Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child. 1991;66:124-129.
31.
Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. Br Med J. 1997;312:1526-1529.
32.
Vanderhoof J, Whitney D, Atonson D, et al.Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564-568.
33.
McFarland L, Surawicz C, Greenberg R. A randomized placeb-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913-1918.
